Related Experiment Videos

Medication changes based on echocardiography in dialysis patients

Chun K Chong1, Michael Muzoora, George J Eckert

  • 1Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

Hemodialysis International. International Symposium on Home Hemodialysis
|June 26, 2009
PubMed

Insights

Serial screening echocardiography in dialysis patients did not significantly alter cardioprotective medication use. These findings suggest routine echocardiograms may not offer added benefit for optimizing cardiovascular disease management in this high-risk population.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Imaging

Background:

  • Dialysis patients face elevated cardiovascular risk.
  • Kidney/Disease Outcome Quality Initiative (K/DOQI) guidelines advocate for echocardiography to detect cardiac disease.
  • Current K/DOQI guidelines recommend baseline echocardiography at dialysis initiation and every 3 years thereafter.

Purpose of the Study:

  • To investigate whether serial screening echocardiography influences cardioprotective medication adjustments in dialysis patients.
  • To test the hypothesis that echocardiography does not alter medication regimens in this population.

Main Methods:

  • Retrospective analysis of medication administration in 231 dialysis patients.
  • Comparison of medication changes in patients with and without echocardiograms.
  • Analysis focused on medication classes including beta blockers, ACEI/ARBs, nitrates, CCBs, and statins.

Main Results:

  • Only 19% of patients in the echocardiogram group had at least one medication class change post-procedure.
  • No significant difference in medication class changes was observed between the echocardiogram and no-echocardiogram groups.
  • Specific medication classes showed minimal changes, with no statistically significant impact attributed to echocardiography.

Conclusions:

  • The occurrence of medication changes post-echocardiography in dialysis patients is infrequent and comparable to routine care.
  • Serial screening echocardiography may not provide additional benefits for optimizing cardiovascular disease management in dialysis patients.
  • Further research is needed to establish the evidence for serial screening echocardiography in this high-risk group.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...